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Abstract
Transient DNA replication assays to detect papillomavirus E1/E2-mediated DNA replication have depended upon Southern blotting. This
technique is hazardous (radioactive), labour intensive, semiquantitative, and physically limited in the number of samples that can be
processed at any one time. We have overcome these problems by developing a real-time PCR protocol for the detection of E1/E2-mediated
transient DNA replication. The results demonstrate detection of replication at levels not seen using Southern blotting demonstrating
enhanced sensitivity. This technique is also, by definition, highly quantitative. Therefore, the real-time PCR technique is the optimal method
for the detection of E1/E2-mediated DNA replication.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Human papillomaviruses (HPVs) are small double-
stranded DNA viruses that infect mucosal or cutaneous
epithelia causing a range of diseases, the most common of
which are skin warts and cervical carcinoma (zur Hausen,
2000). HPVs replicate their genome as episomal DNA using
two viral proteins, E1 and E2 (LaPorta and Taichman,
1982). HPV E1 and E2 proteins interact and form a complex
at the viral origin of replication (Ori) and cooperatively
recruit the cellular replication machinery to the viral ge-
nome (Chiang et al., 1992; Del Vecchio et al., 1992). E1 is
an ATP-dependent DNA helicase that interacts with an
AT-rich binding site at the Ori, where it interacts with
cellular partners (DNA polymerase  primase, SWI/SNF)
and E2 (Hughes and Romanos, 1993; Park et al., 1994;
Masterston et al., 1998; Lee et al., 1999). E2 is a multifunc-
tional protein that controls the transcription and replication
of the viral genome through interaction with cellular part-
ners and E1 (Bouvard et al., 1994; Berg and Stenlund,
1997). Interaction between E1 and E2 is essential for rep-
lication of the viral genome, E2 binds to DNA binding sites
that flank the E1 binding site, and the N-terminal of E2
interacts with E1 and aids E1 recruitment to the origin of
replication (Chao et al., 1999; Titolo et al., 1999).
Assaying the viral genome replication functions of HPV
E1 and E2 proteins is done using an in vivo transient
replication assay and this has been a successful approach for
numerous HPV types (Chiang et al., 1992). Briefly, a tran-
sient replication assay involves the replication in vivo of a
plasmid that contains an HPV origin (pOri) by transiently
expressed E1 and E2 proteins. The freshly replicated pOri
are differentiated from transfected input pOri by the selec-
tive digestion of input, but not replicated molecules, by the
DpnI restriction enzyme. DpnI can only digest DNA that is
dam methylated (dam positive, a bacterial-specific methyl-
ation); therefore, replicated pOri in mammalian cells are
dam negative and DpnI resistant. Traditionally, the freshly
replicated pOri are detected by Southern blotting, which
results in limitations on experiment size and design. Real-
time PCR is an established technique for precise and rapid
quantitation of specific DNA sequences (Heid et al., 1996)
and here we report the development of a transient assay for
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detection of HPV-16 E1 and E2 DNA replication using
real-time PCR.
Results and discussion
Real-time PCR-based detection protocol
Quantitation of DNA using real-time PCR relies on the
use of a specific primer and probe set designed against the
target template. In this case it was a region of the HPV16
origin of replication cloned into pOri16M (Fig. 1a). To
differentiate between input pOri16M transfected into the
cells and the freshly replicated molecules, pOri16M has a
point mutation in a nonessential part of the origin of repli-
cation creating a DpnI restriction site within the probe
binding site (Fig. 1b). On sample treatment with DpnI only
input DNA is digested, completely disrupting the PCR am-
plicon essential for the detection of the pOri16M. Freshly
replicated molecules are DpnI resistant and therefore de-
tected using real-time PCR. To remove any residual DNA
fragments the samples were treated with Exonuclease III;
this enzyme will not digest the freshly replicated circular
non-DpnI-digested DNA.
Titration of pOri16M into transient replication assay
At 1 g of input pOri16M there is a 10-fold difference
between nonreplicating background samples and replicating
samples (Fig. 2). As the amount of pOri16M is reduced by
10-fold the amount of background is reduced until it reaches
0 at 100 pg of pOri16M. Significantly, as pOri16M is
reduced, the amount of replication falls by a relatively small
amount (5-fold from 1 g of pOri16M to 1 ng of
pOri16M), whereas the background is reduced by 1000-
fold. At 100 pg of pOri16M transfected, the level of
pOri16M significantly limits the amount of replication able
to occur; at this point the replication is on a linear scale.
Each sample used for the real-time PCR was linearized
(XmnI), DpnI treated, and a Southern blot was performed to
allow comparison to the real-time PCR protocol. The South-
ern blot can clearly detect replication from 1 g to 1 ng of
pOri16M and can barely detect it at 100 pg of pOri16M. The
blot is unable to detect any pOri16M in all the nonreplicat-
ing samples, presumably because the fragments that give the
background signal with the PCR samples are a different size
from the full-length pOri16M.
E2 titration with 1 ng of pOri16M
To evaluate the sensitivity of the real-time PCR protocol
a titration of E2 expression plasmid was transfected into the
system with 1 ng of pOri16M (Fig. 3). Replication peaked
with 100 ng of E2 transfected, at 1 and 10 ng of E2 the
replication is suboptimal, and at 1 g of E2 there is a
decrease in replication probably due to “squelching.” Also
there is no detectable replication with just E1 or E2 ex-
Fig. 1. Design of real-time PCR-based replication assay. Outline of pOri16M. Dark grey shaded area is the minimal origin of replication from HPV16 (nt
7838–139) cloned into pSK II(). This contains one E1 binding site and three E2 binding sites. The real-time PCR primers and probe were designed against
nt 49–139 and are shown. Within the probe binding site is the sequence GATC, a DpnI restriction site. This was created by point mutation of nt 115 from
C to T, the mutated T is underlined. “F” is the reporter FAM fluorochrome and “T” is the quencher fluorochrome.
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pressed individually confirming that cooperation between
E1 and E2 is required for replication of pOri16M.
Comparing the results for the real-time PCR with the
Southern blot reveals that the real-time PCR detection
method is more sensitive at detecting replication. The
Southern blot could only detect replication at 100 ng of E2
with 1 ng of pOri16M. Real-time PCR is able to detect viral
DNA replication at levels at least 100-fold lower than the
Southern blot can detect. This experiment highlights the
increased sensitivity of the real-time PCR protocol.
Use of MboI for internal control
To internally control a replication assay the quantitation
of the amount of input pOri16M is an effective method for
controlling against variation in transfection and DNA har-
vest efficiency. To use this method with real-time PCR we
digested our samples with MboI. The restriction site for
MboI is the same as DpnI (GATC) except MboI can only
digest DNA that is dam negative; it is blocked by the
methylation on dam-positive DNA. This results in the di-
gestion of freshly replicated pOri16M in the sample and
dam-positive input DNA are detected using real-time PCR.
An experiment using MboI-digested samples from Fig. 3a
(1 ng of pOri16M with E2 titration) was done using real-
time PCR (Fig. 3b). This demonstrates the clear detection of
the transfected input pOri16M and the consistency between
samples.
Detection of TopBP1-enhanced replication in C33a cells
We have previously demonstrated that the E2 interacting
protein TopBP1 enhances E1/E2-mediated replication in
U2OS cells using Southern blotting. Similar experiments in
C33a cells showed that there was no difference in the level
of replication observed with TopBP1 overexpression using
Southern blotting (Boner et al., 2002). To highlight the
benefits of the increased sensitivity the real-time PCR pro-
tocol offers, we have overexpressed TopBP1 with submaxi-
mal levels of E2 (1 and 10 ng) (Fig. 4) with 1 ng of
pOri16M in C33a cells. Overexpression of TopBP1 signif-
icantly enhances the E1/E2-dependent replication with a
5-fold increase using 1 ng of E2 and a 2.5-fold increase
using 10 ng of E2. Therefore, there is a significant effect on
E1/E2-mediated DNA replication following TopBP1 over-
expression that was not possible to detect using Southern
Fig. 2. A titration of the amount of pOri16M transfected with either no E1 and E2 or with E1 and E2 cotransfected. Samples were analyzed with both real-time
PCR and Southern blot. Real-time PCR results are plotted on a bar chart and the Southern blot is below. Real-time PCR samples were digested with DpnI
and Southern blot samples were digested with DpnI and XmnI to reveal linear replicated pOri16M at 3 kb. The PCR experiments were carried out at least
two times in triplicate and the standard error bars are shown.
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Fig. 3. (a) Titration of E2 with 1 ng of pOri16M transfected. Samples were analyzed with both real-time PCR and Southern blot. Real-time PCR samples
were digested with DpnI and Southern blot samples were digested with DpnI and XmnI to reveal linear replicated pOri16M at 3 kb. (b) Detection of input
pOri16M for use as an internal control. MboI digests the replicated dam-negative DNA leaving the dam-positive DNA detected by real-time PCR. Samples
from Fig. 3a were MboI treated and analyzed using real-time PCR. The PCR experiments were carried out at least two times in triplicate and the standard
error bars are shown.
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blotting in C33a cells. This demonstrates that the real-time
protocol described here has enhanced sensitivity and quan-
titation for assaying E1/E2-mediated DNA replication.
In this study a real-time PCR assay for the detection of
HPV16 transient viral DNA replication is described and
compared to the traditional Southern blot method. When an
optimal level of pOri16M is used (1 ng) the real-time PCR
assay is a highly sensitive and quantitative method for
detection of transient viral DNA replication. Importantly, it
allows for detection of replication at origin input levels
where the replication mediated by E1/E2 is on a linear scale.
This cannot be said for the Southern blotting technique; this
advantage has resulted in the detection of enhanced repli-
cation by TopBP1 in C33a cells, something that was not
possible using Southern blotting (Boner et al., 2002). This
demonstrates the benefit of this system over Southern blot-
ting; more subtle effects on DNA replication are highlighted
using the optimized conditions with the real-time PCR pro-
tocol. This is ideal for looking at the way HPV DNA
elements and E1/E2 control viral DNA replication. Finally,
real-time PCR is a significantly faster way to generate
results; use of 96-well plates and a 2-h run time creates a
high throughput assay that has potential for commercial
application. Disruption of the E1/E2 interaction prevents
viral DNA replication (Yasugi et al., 1997; Kasukawa et al.,
1998) and is an attractive target for HPV drug development
(Plumpton et al., 1995; Clark et al., 1998). The real-time
PCR assay described here is an ideal template for the de-
velopment of a screen for the discovery of HPV antiviral
compounds.
Materials and methods
Plasmids
HPV E1 and E2 expression plasmids have been described
(Sakai et al., 1996). The pOri16M is a modified version of
pOri16 described (Sakai et al., 1996). The HPV16 Ori (nt
7838–139) was PCR amplified from pOri16 with a primer
containing a point mutation at nt 115 (C to T) of the HPV-16
genome creating a DpnI site (GATC). The PCR fragment was
cloned as an EcoRI/BamHI fragment into pSKII(). Primers
used were: 5-Oritaq (GTACGGATCCTGCACATGGGTGT-
GTGCAA) and 3-Oritaq (GTACGAATTCTAACTTTCT-
GGGTCGCTCCTGTGGATCCTG). The point mutation is
underlined. The TopBP1 expression vector has been described
previously (Yamane et al., 2002).
Fig. 4. Increased replication with overexpression of TopBP1. Internally controlled detection of replication using either 1 or 10 ng of E2, with or without 1
g of TopBP1. Data shown are the DpnI digest of each sample detected with the real-time PCR protocol. The PCR experiments were carried out at least
two times in triplicate and the standard error bars are shown.
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Transfection and DNA harvest
C33a cells were grown in DMEM supplemented with
10% FCS and split 1:10 every 3 to 4 days. Replication
assays were carried out as previously described (Boner et
al., 2002). Briefly, 6  105 C33a were plated out in 100-
mm2 dishes and the following day transfected using the
calcium phosphate method. Three days post transfection
low molecular weight DNA was extracted using the Hirt
method. Cells were lysed in 800 l of Hirt solution (0.6%
SDS, 10 mM EDTA), scraped into a 1.5-ml microcentrifuge
tube; 200 l of 5 M NaCl was added and the sample were
then left at 4°C overnight. After centrifugation, 30 min at
4°C, they were extracted once with phenol-chloroform-
isoamyl alcohol and precipitated with ethanol. Following
centrifugation the DNA pellet was washed with 70% etha-
nol, dried, then resuspended in 100 l of H2O, and the
sample was analyzed by real-time PCR and Southern blot.
Real-time PCR
The design of primers and probes was carried out using
Primer Express software (PE Applied Biosystems). The
primer set chosen amplifies a 99-bp region of the HPV16
Ori cloned into pOri16M and has the DpnI site at the 3 end
of the probe binding site. PCR conditions were optimized
and were found to be 5.5 mM MgCl2; 200 M dATP,
dCTP, and dGTP; 400 M dUTP; 900 nM of each primer;
100 nM probe and 1 U of Amplitaq per reaction. PCR
reactions were performed on a sequence detection system
(ABI Prism 7700, Applied Biosystems) according to the
manufacturer’s instructions by using universal PCR condi-
tions (95°C for 30 s and 60°C for 1 min, in 40 cycles).
To differentiate between replicated and input molecules
of pOri16M, harvested DNA was digested with either DpnI
or MboI. DpnI will only digest the GATC site when both
strands are dam methylated and MboI digestion is only
possible when both strands are unmethylated. Therefore
DpnI will not digest the replicated DNA and MboI will not
digest the input DNA.
To detect replicated pOri16M 25 l of sample was di-
gested with DpnI, or to detect input pOri16M 25 l of
sample was digested with MboI, each digested overnight.
Treatment of each sample with Exonuclease III for 30 min
reduces the background that is seen with real-time PCR due
to incompletely digested DNA. Exonuclease III is then heat
inactivated by heating each sample to 70°C for 30 min; 10
l of each treated sample was run in triplicate using real-
time PCR. Quantitation was performed using a 12-step
standard curve from a pOri16M dilution series of 100 to
105 pg.
Southern blot
Sample (25 l) was digested with DpnI and XmnI over-
night to reveal linear replicated pOri16M at 3 kb. Digested
samples were separated by 1.0% agarose gel electrophoresis
and analyzed by Southern blotting. Blots were probed using
a 700-bp HPV16 Ori-containing fragment released from
pOri16M by PvuII restriction digest and 32P-radiolabeled
using the Stratagene Prime-It II kit. Blots were hybridized
using Quikhyb solution (Stratagene). Blots were washed to
0.1  SSC and developed using a Storm 870 Molecular
Dynamics PhosphorImager.
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